- Home
- SNY vs SAN Comparison
SNY vs SAN Comparison
Compare SNY & SAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- SAN
- Stock Information
- Founded
- SNY 1994
- SAN 1857
- Country
- SNY France
- SAN Spain
- Employees
- SNY N/A
- SAN N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- SAN Commercial Banks
- Sector
- SNY Health Care
- SAN Finance
- Exchange
- SNY Nasdaq
- SAN Nasdaq
- Market Cap
- SNY 116.5B
- SAN 126.8B
- IPO Year
- SNY N/A
- SAN 1987
- Fundamental
- Price
- SNY $48.32
- SAN $8.43
- Analyst Decision
- SNY Buy
- SAN Strong Buy
- Analyst Count
- SNY 2
- SAN 1
- Target Price
- SNY $62.50
- SAN N/A
- AVG Volume (30 Days)
- SNY 2.0M
- SAN 8.0M
- Earning Date
- SNY 07-31-2025
- SAN 07-28-2025
- Dividend Yield
- SNY 3.31%
- SAN 2.00%
- EPS Growth
- SNY 39.56
- SAN 20.30
- EPS
- SNY 5.45
- SAN 0.87
- Revenue
- SNY $48,817,552,946.00
- SAN $54,835,711,180.00
- Revenue This Year
- SNY $3.39
- SAN $23.44
- Revenue Next Year
- SNY $7.05
- SAN $2.47
- P/E Ratio
- SNY $8.86
- SAN $9.63
- Revenue Growth
- SNY N/A
- SAN 6.36
- 52 Week Low
- SNY $45.80
- SAN $4.27
- 52 Week High
- SNY $60.12
- SAN $8.90
- Technical
- Relative Strength Index (RSI)
- SNY 45.01
- SAN 54.05
- Support Level
- SNY $47.87
- SAN $8.28
- Resistance Level
- SNY $48.80
- SAN $8.54
- Average True Range (ATR)
- SNY 0.58
- SAN 0.12
- MACD
- SNY 0.10
- SAN -0.03
- Stochastic Oscillator
- SNY 28.85
- SAN 33.80
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
About SAN Banco Santander S.A. Sponsored ADR (Spain)
Santander's focus is on retail and commercial banking. Latin America is geographically the most significant operation, with Brazil making the largest contribution. Its continental European business is mainly in Spain and Portugal. Santander's UK presence is the result of its acquisition of Abbey building society. In the US, Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.